Absci Price Target Maintained With a $10.00/Share by Guggenheim
Absci to Participate in the 36th Annual Piper Sandler Healthcare Conference
AI's Growing Role in Transforming Healthcare Delivers Innovations in Diagnostics, Patient Care
Stifel Maintains Absci Corp(ABSI.US) With Hold Rating, Maintains Target Price $6
Absci Analyst Ratings
Scotiabank Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $13
H.C. Wainwright Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $7
Q3 2024 Absci Corp Earnings Call
Express News | Absci Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 Financial Results
TD Cowen Initiates Absci Corp(ABSI.US) With Buy Rating
Absci Corp | 10-Q: Q3 2024 Earnings Report
Absci Corporation (ABSI) Q3 2024 Earnings Call Transcript
Absci Corp | 8-K: Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results
Express News | Absci Q3 2024 GAAP EPS $(0.24) Misses $(0.20) Estimate, Sales $1.701M Miss $1.753M Estimate
Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results
Absci 3Q Rev $1.7M >ABSI
Absci 3Q Loss/Shr 24c >ABSI
Absci 3Q Loss $27.4M >ABSI
Express News | Absci Q3 Operating Expenses USD 30.596 Million
Express News | Absci Q3 Basic EPS USD -0.24